dr. randall on next steps with parp inhibitors in gynecologic malignancies
Published 5 years ago • 133 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
6:20
parp inhibitors in recurrent ovarian cancer
-
0:41
understand the adverse events of parp inhibitors
-
0:54
dr. randall on emerging treatment strategies in cervical cancer
-
24:56
gynecologic cancer education: parp inhibitor therapy
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
3:39
dna damage response
-
12:24
the role of targeting dna repair with parp
-
3:12
how parp inhibitors (parpi) work
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
1:52
dr. schilder on parp inhibitors in gynecologic cancers
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
18:37
ongoing clinical trials with parp inhibitors in ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer